BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Knight FC, Gilchuk P, Kumar A, Becker KW, Sevimli S, Jacobson ME, Suryadevara N, Wang-Bishop L, Boyd KL, Crowe JE Jr, Joyce S, Wilson JT. Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8+ Lung-Resident Memory T Cells. ACS Nano 2019;13:10939-60. [PMID: 31553872 DOI: 10.1021/acsnano.9b00326] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 17.3] [Reference Citation Analysis]
Number Citing Articles
1 Pei Z, Chen S, Ding L, Liu J, Cui X, Li F, Qiu F. Current perspectives and trend of nanomedicine in cancer: A review and bibliometric analysis. Journal of Controlled Release 2022;352:211-241. [DOI: 10.1016/j.jconrel.2022.10.023] [Reference Citation Analysis]
2 Wei Q, Liu S, Huang X, Xin H, Ding J. Immunologically effective biomaterials-enhanced vaccines against infection of pathogenic microorganisms. Biosafety and Health 2022. [DOI: 10.1016/j.bsheal.2022.11.002] [Reference Citation Analysis]
3 Valenzuela-fernández A, Cabrera-rodriguez R, Ciuffreda L, Perez-yanes S, Estevez-herrera J, González-montelongo R, Alcoba-florez J, Trujillo-gonzález R, García-martínez de Artola D, Gil-campesino H, Díez-gil O, Lorenzo-salazar JM, Flores C, Garcia-luis J. Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19. Front Bioeng Biotechnol 2022;10. [DOI: 10.3389/fbioe.2022.1052436] [Reference Citation Analysis]
4 De Mel J, Hossain M, Shofolawe-bakare O, Mohammad SA, Rasmussen E, Milloy K, Shields M, Roth EW, Arora K, Cueto R, Tang S, Wilson JT, Smith AE, Werfel TA. Dual-Responsive Glycopolymers for Intracellular Codelivery of Antigen and Lipophilic Adjuvants. Mol Pharmaceutics 2022. [DOI: 10.1021/acs.molpharmaceut.2c00750] [Reference Citation Analysis]
5 Suryadevara N, Kumar A, Ye X, Rogers M, Williams JV, Wilson JT, Karijolich J, Joyce S. A molecular signature of lung-resident CD8+ T cells elicited by subunit vaccination. Sci Rep 2022;12:19101. [DOI: 10.1038/s41598-022-21620-7] [Reference Citation Analysis]
6 Lam JH, Shivhare D, Chia TW, Chew SL, Sinsinbar G, Aw TY, Wong S, Venkataraman S, Lim FWI, Vandepapeliere P, Nallani M. Artificial Cell Membrane Polymersome-Based Intranasal Beta Spike Formulation as a Second Generation Covid-19 Vaccine. ACS Nano 2022. [PMID: 36223228 DOI: 10.1021/acsnano.2c06350] [Reference Citation Analysis]
7 Chen J, Peng Q, Peng X, Zhang H, Zeng H. Probing and Manipulating Noncovalent Interactions in Functional Polymeric Systems. Chem Rev 2022. [PMID: 36054924 DOI: 10.1021/acs.chemrev.2c00215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zhou W, Yang J, Zhang Y, Hu X, Wang W. Current landscape of gene-editing technology in biomedicine: Applications, advantages, challenges, and perspectives. MedComm (2020) 2022;3:e155. [PMID: 35845351 DOI: 10.1002/mco2.155] [Reference Citation Analysis]
9 Salman A, Kantor A, Mcclements ME, Marfany G, Trigueros S, Maclaren RE. Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations. Pharmaceutics 2022;14:1842. [DOI: 10.3390/pharmaceutics14091842] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Waheed S, Li Z, Zhang F, Chiarini A, Armato U, Wu J. Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery. J Nanobiotechnology 2022;20:395. [PMID: 36045386 DOI: 10.1186/s12951-022-01605-4] [Reference Citation Analysis]
11 Zhang M, Li N, He Y, Shi T, Jie Z. Pulmonary resident memory T cells in respiratory virus infection and their inspiration on therapeutic strategies. Front Immunol 2022;13:943331. [DOI: 10.3389/fimmu.2022.943331] [Reference Citation Analysis]
12 Du G, Qin M, Sun X. Recent progress in application of nanovaccines for enhancing mucosal immune responses. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.08.010] [Reference Citation Analysis]
13 Li M, Chen C, Wang X, Guo P, Feng H, Zhang X, Zhang W, Gu C, Zhu J, Wen G, Rao VB, Tao P. Rapid Development of a Mucosal Nanoparticle Flu Vaccine by Genetic Engineering of Bacteriophage T4 using CRISPR-Cas.. [DOI: 10.1101/2022.06.13.495850] [Reference Citation Analysis]
14 Baljon JJ, Wilson JT. Bioinspired vaccines to enhance MHC class-I antigen cross-presentation. Curr Opin Immunol 2022;77:102215. [PMID: 35667222 DOI: 10.1016/j.coi.2022.102215] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hartmeier PR, Kosanovich JL, Velankar KY, Armen-Luke J, Lipp MA, Gawalt ES, Giannoukakis N, Empey KM, Meng WS. Immune Cells Activating Biotin-Decorated PLGA Protein Carrier. Mol Pharm 2022. [PMID: 35621214 DOI: 10.1021/acs.molpharmaceut.2c00343] [Reference Citation Analysis]
16 Chen N, He Y, Zang M, Zhang Y, Lu H, Zhao Q, Wang S, Gao Y. Approaches and materials for endocytosis-independent intracellular delivery of proteins. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Files MA, Naqvi KF, Saito TB, Clover TM, Rudra JS, Endsley JJ. Self-adjuvanting nanovaccines boost lung-resident CD4+ T cell immune responses in BCG-primed mice. NPJ Vaccines 2022;7:48. [PMID: 35474079 DOI: 10.1038/s41541-022-00466-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Jiang H, Li L, Zhu D, Zhou X, Yu Y, Zhou Q, Sun L. A Review of Nanotechnology for Treating Dysfunctional Placenta. Front Bioeng Biotechnol 2022;10:845779. [DOI: 10.3389/fbioe.2022.845779] [Reference Citation Analysis]
19 Stickdorn J, Stein L, Arnold-Schild D, Hahlbrock J, Medina-Montano C, Bartneck J, Ziß T, Montermann E, Kappel C, Hobernik D, Haist M, Yurugi H, Raabe M, Best A, Rajalingam K, Radsak MP, David SA, Koynov K, Bros M, Grabbe S, Schild H, Nuhn L. Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors. ACS Nano 2022;16:4426-43. [PMID: 35103463 DOI: 10.1021/acsnano.1c10709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
20 Carson CS, Becker KW, Garland KM, Pagendarm HM, Stone PT, Arora K, Wang-Bishop L, Baljon JJ, Cruz LD, Joyce S, Wilson JT. A nanovaccine for enhancing cellular immunity via cytosolic Co-delivery of antigen and PolyIC RNA. J Control Release 2022:S0168-3659(22)00146-8. [PMID: 35301055 DOI: 10.1016/j.jconrel.2022.03.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Alphandéry E. Nano dimensions/adjuvants in COVID-19 vaccines. J Mater Chem B 2022. [PMID: 35166754 DOI: 10.1039/d1tb02408f] [Reference Citation Analysis]
22 Ljubimov VA, Ramesh A, Davani S, Danielpour M, Breunig JJ, Black KL. Neurosurgery at the crossroads of immunology and nanotechnology. New reality in the COVID-19 pandemic. Adv Drug Deliv Rev 2022;181:114033. [PMID: 34808227 DOI: 10.1016/j.addr.2021.114033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Dong C, Wang Y, Zhu W, Ma Y, Kim J, Wei L, Gonzalez GX, Wang BZ. Polycationic HA/CpG Nanoparticles Induce Cross-Protective Influenza Immunity in Mice. ACS Appl Mater Interfaces 2022. [PMID: 35084819 DOI: 10.1021/acsami.1c19192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Sharma J, Carson CS, Douglas T, Wilson JT, Joyce S. Nano-Particulate Platforms for Vaccine Delivery to Enhance Antigen-Specific CD8+ T-Cell Response. Vaccine Design 2022. [DOI: 10.1007/978-1-0716-1892-9_19] [Reference Citation Analysis]
25 Tang W, Zhang Y, Zhu G. Pulmonary delivery of mucosal nanovaccines. Nanoscale 2021. [PMID: 34918733 DOI: 10.1039/d1nr06512b] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
26 Huang S, Zhu Y, Zhang L, Zhang Z. Recent Advances in Delivery Systems for Genetic and Other Novel Vaccines. Adv Mater 2021;:e2107946. [PMID: 34914144 DOI: 10.1002/adma.202107946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Garland KM, Rosch JC, Carson CS, Wang-Bishop L, Hanna A, Sevimli S, Van Kaer C, Balko JM, Ascano M, Wilson JT. Pharmacological Activation of cGAS for Cancer Immunotherapy. Front Immunol 2021;12:753472. [PMID: 34899704 DOI: 10.3389/fimmu.2021.753472] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
28 Dong C, Wang B. Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats. Advanced NanoBiomed Research 2022;2:2100122. [DOI: 10.1002/anbr.202100122] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Cordeiro AS, Patil-Sen Y, Shivkumar M, Patel R, Khedr A, Elsawy MA. Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application. Pharmaceutics 2021;13:2091. [PMID: 34959372 DOI: 10.3390/pharmaceutics13122091] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
30 Jeong H, Lee CS, Lee J, Lee J, Hwang HS, Lee M, Na K. Hemagglutinin Nanoparticulate Vaccine with Controlled Photochemical Immunomodulation for Pathogenic Influenza-Specific Immunity. Adv Sci (Weinh) 2021;8:e2100118. [PMID: 34693665 DOI: 10.1002/advs.202100118] [Reference Citation Analysis]
31 Nagareddy R, Thomas RG, Jeong YY. Stimuli-Responsive Polymeric Nanomaterials for the Delivery of Immunotherapy Moieties: Antigens, Adjuvants and Agonists. Int J Mol Sci 2021;22:12510. [PMID: 34830392 DOI: 10.3390/ijms222212510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Iyer S, Yadav R, Agarwal S, Tripathi S, Agarwal R. Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases. Clin Microbiol Rev 2021;:e0012321. [PMID: 34788128 DOI: 10.1128/CMR.00123-21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
33 Yuan R, Yu J, Jiao Z, Li J, Wu F, Yan R, Huang X, Chen C. The Roles of Tissue-Resident Memory T Cells in Lung Diseases. Front Immunol 2021;12:710375. [PMID: 34707601 DOI: 10.3389/fimmu.2021.710375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
34 Zheng MZM, Wakim LM. Tissue resident memory T cells in the respiratory tract. Mucosal Immunol 2021. [PMID: 34671115 DOI: 10.1038/s41385-021-00461-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
35 Lin XM, Shi XX, Xiong L, Nie JH, Ye HS, Du JZ, Liu J. Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects. Int J Mol Sci 2021;22:10622. [PMID: 34638961 DOI: 10.3390/ijms221910622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Ritzau-Jost J, Hutloff A. T Cell/B Cell Interactions in the Establishment of Protective Immunity. Vaccines (Basel) 2021;9:1074. [PMID: 34696182 DOI: 10.3390/vaccines9101074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
37 Durán-Lobato M, López-Estévez AM, Cordeiro AS, Dacoba TG, Crecente-Campo J, Torres D, Alonso MJ. Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape. Adv Drug Deliv Rev 2021;176:113899. [PMID: 34314784 DOI: 10.1016/j.addr.2021.113899] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
38 Pang G, Liu Y, Wang Y, Wang Y, Wang F, Zhao J, Zhang LW. Endotoxin contamination in ovalbumin as viewed from a nano-immunotherapy perspective. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;:e1747. [PMID: 34374214 DOI: 10.1002/wnan.1747] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Yang Z, Hua L, Yang M, Liu SQ, Shen J, Li W, Long Q, Bai H, Yang X, Ren Z, Zheng X, Sun W, Ye C, Li D, Zheng P, He J, Chen Y, Huang W, Peng X, Ma Y. RBD-Modified Bacterial Vesicles Elicited Potential Protective Immunity against SARS-CoV-2. Nano Lett 2021;21:5920-30. [PMID: 34279108 DOI: 10.1021/acs.nanolett.1c00680] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
40 Musale S, Giram P, Department of Pharmaceutics, Dr. D. Y. Patil Unitech Society’s Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Sant Tukaram Nagar, Pimpri, Pune - 411 018, Maharashtra, India. NOSE TO BRAIN DELIVERY: ROLE OF VIRAL AND NON-VIRAL VECTORS FOR NEUROLOGICAL DISORDER. Ind Dru 2021;58:7-20. [DOI: 10.53879/id.58.05.12489] [Reference Citation Analysis]
41 Wang Z, van Drunen Littel-van den Hurk S, Chen L. Chitosan nanoparticles fabricated through host-guest interaction for enhancing the immunostimulatory effect of CpG oligodeoxynucleotide. Carbohydr Polym 2021;271:118417. [PMID: 34364558 DOI: 10.1016/j.carbpol.2021.118417] [Reference Citation Analysis]
42 Yang J, Jia C, Yang J. Designing Nanoparticle-based Drug Delivery Systems for Precision Medicine. Int J Med Sci 2021;18:2943-9. [PMID: 34220321 DOI: 10.7150/ijms.60874] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
43 Derakhshan MA, Amani A, Faridi-Majidi R. State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2. ACS Appl Mater Interfaces 2021;13:14816-43. [PMID: 33779135 DOI: 10.1021/acsami.0c22381] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
44 Kelly SH, Cossette BJ, Varadhan AK, Wu Y, Collier JH. Titrating Polyarginine into Nanofibers Enhances Cyclic-Dinucleotide Adjuvanticity in Vitro and after Sublingual Immunization. ACS Biomater Sci Eng 2021;7:1876-88. [DOI: 10.1021/acsbiomaterials.0c01429] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
45 Lin PH, Liang CY, Yao BY, Chen HW, Pan CF, Wu LL, Lin YH, Hsu YS, Liu YH, Chen PJ, Hu CJ, Yang HC. Robust induction of TRMs by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza viruses. Mol Ther Methods Clin Dev 2021;21:299-314. [PMID: 33898629 DOI: 10.1016/j.omtm.2021.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Wang S. pH-Responsive Amphiphilic Carboxylate Polymers: Design and Potential for Endosomal Escape. Front Chem 2021;9:645297. [PMID: 33834015 DOI: 10.3389/fchem.2021.645297] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
47 Chen F, Wang Y, Gao J, Saeed M, Li T, Wang W, Yu H. Nanobiomaterial-based vaccination immunotherapy of cancer. Biomaterials 2021;270:120709. [PMID: 33581608 DOI: 10.1016/j.biomaterials.2021.120709] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 30.0] [Reference Citation Analysis]
48 Knight FC, Wilson JT. Engineering Vaccines for Tissue-Resident Memory T Cells. Adv Ther (Weinh) 2021;4:2000230. [PMID: 33997268 DOI: 10.1002/adtp.202000230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
49 Gao X, Wang M. Nanoparticles for intracellular protein delivery. Reference Module in Materials Science and Materials Engineering 2021. [DOI: 10.1016/b978-0-12-822425-0.00019-1] [Reference Citation Analysis]
50 Cossette B, Kelly SH, Collier JH. Intranasal Subunit Vaccination Strategies Employing Nanomaterials and Biomaterials. ACS Biomater Sci Eng 2021;7:1765-79. [DOI: 10.1021/acsbiomaterials.0c01291] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
51 Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 2021;20:101-24. [PMID: 33277608 DOI: 10.1038/s41573-020-0090-8] [Cited by in Crossref: 1076] [Cited by in F6Publishing: 1167] [Article Influence: 538.0] [Reference Citation Analysis]
52 Jacobson ME, Becker KW, Palmer CR, Pastora LE, Fletcher RB, Collins KA, Fedorova O, Duvall CL, Pyle AM, Wilson JT. Structural Optimization of Polymeric Carriers to Enhance the Immunostimulatory Activity of Molecularly Defined RIG-I Agonists. ACS Cent Sci 2020;6:2008-22. [PMID: 33274278 DOI: 10.1021/acscentsci.0c00568] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
53 Shae D, Baljon JJ, Wehbe M, Christov PP, Becker KW, Kumar A, Suryadevara N, Carson CS, Palmer CR, Knight FC, Joyce S, Wilson JT. Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines. ACS Nano 2020;14:9904-16. [PMID: 32701257 DOI: 10.1021/acsnano.0c02765] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 26.5] [Reference Citation Analysis]
54 He H, Shi X, Chen W, Chen R, Zhao C, Wang S. Temperature/pH Smart Nanofibers with Excellent Biocompatibility and Their Dual Interactions Stimulus-Responsive Mechanism. J Agric Food Chem 2020;68:7425-33. [PMID: 32559369 DOI: 10.1021/acs.jafc.0c01493] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
55 Van Hoecke L, Verbeke R, De Vlieger D, Dewitte H, Roose K, Van Nevel S, Krysko O, Bachert C, Schepens B, Lentacker I, Saelens X. mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice. Mol Ther Nucleic Acids 2020;20:777-87. [PMID: 32438313 DOI: 10.1016/j.omtn.2020.04.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
56 Schirrmacher V. New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection. Biomedicines 2020;8:E55. [PMID: 32155856 DOI: 10.3390/biomedicines8030055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]